Dr. Daniel Cary Rausch, MD

Dr. Rausch practices at Central Maine Medical Center in Lewiston, Maine, part of Prime Healthcare Services.

Dr. Rausch's NPI, 1649478827, was assigned on July 10, 2007. Dr. Rausch graduated from Tufts University School of Medicine in 2004. Dr. Rausch holds Maine license 018315.

Dr. Rausch's primary practice is Central Maine Medical Center, at 300 Main Street, Lewiston, ME 04240 in Androscoggin County. The practice phone is (207) 795-0111.

Dr. Rausch's primary practice is Central Maine Medical Center in Lewiston, Maine, part of Prime Healthcare Services. Dr. Rausch is also affiliated with St. Mary's Regional Medical Center. The medical group on file is Central Maine Medical Center. Dmand AI also links Dr. Rausch to 3 more hospitals, 3 medical groups, 1 group practice or clinic, 1 home health agency and 1 hospice, each named with a free account. Dr. Rausch's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rausch practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Rausch's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Rausch's licenses on file in 2 states: Maine and New Hampshire.

CMS data shows 617 Medicare services from Dr. Rausch across 5 procedure codes in 2024, all of them office visits, for 224 Medicare patients. Medicare paid $51,580 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 224 Medicare patients who saw Dr. Rausch in 2024. The largest group is 65 to 74, with 89 patients. 66% of them have high cholesterol, and 64% have high blood pressure. 31% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rausch's median patient age at 73, with 50% women.

In 2024, Dr. Rausch wrote 1,452 Medicare Part D claims for 250 patients. 75% of them were for generic drugs. CMS names the drug for 1,167 of them, across 37 drugs with 11 or more claims each, at $3,092,175 in total drug cost. In 2023, CMS named 264 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Rausch for performance year 2024, reported through an alternative payment model (APM). Dr. Rausch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rausch as offering telehealth.

CMS Open Payments shows 527 general payments to Dr. Rausch from 48 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. Astellas Pharma Global Development paid the most, $14,361.

Dr. Rausch graduated from Tufts University School of Medicine in 2004.